-Uluru Inc and Exciton to Develop Altrazeal Exsalt Antimicrobial Dressing Product
M2 EquityBites › January 20, 2011
Linked as:
M2 EquityBites › January 20, 2011
Linked as:Summary
EQUITYBITES-(C)2011 M2 COMMUNICATIONS
Pharmaceutical company ULURU Inc (NYSE Alternext:ULU) stated on Wednesday that the company has signed a Binding Letter of Intent to develop an antimicrobial dressing product.See the full content of this document
Extract
-Uluru Inc and Exciton to Develop Altrazeal Exsalt Antimicrobial Dressing Product
Under the agreement with Exciton Technologi...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United Kingdom
Explore vLex
For Professionals
For Partners
Company
Other documents:
What a Crack | Levein s Bitter Swede Experience of Friendlies has Left Him Wary of Big Names | S4c Viewing Figures Show an Increase Your Letters to the National Newspaper of Wales | Jcr-Vis Places Telecard Tfc On 'Developing' Watch | Alltel Corp. the parent company of Midwest Wireless is cutting 150 people from the Midwest Wireless payroll mostly in the Mankato Minn. headqu... | Industry Thought Leader and Veteran David Stodder Joins Ventana Research. | Zep Inc to Discuss Second Quarter Results. | SUEZ finalizes plans for LNG terminal in Chile.